Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 28246467)

  • 1. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial Pancreatic Cancer and Surveillance of High-Risk Individuals.
    Matsubayashi H; Takaori K; Morizane C; Kiyozumi Y
    Gut Liver; 2019 Sep; 13(5):498-505. PubMed ID: 30917631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
    Matsubayashi H
    J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    Ohmoto A; Yachida S; Morizane C
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of germline BRCA1 & BRCA2 mutations in familial pancreatic cancer: A systematic review and meta-analysis.
    Limijadi EKS; Muniroh M; Prajoko YW; Tjandra KC; Respati DRP
    PLoS One; 2024; 19(5):e0299276. PubMed ID: 38809921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
    Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
    Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial pancreatic carcinoma in Jews.
    Lynch HT; Deters CA; Lynch JF; Brand RE
    Fam Cancer; 2004; 3(3-4):233-40. PubMed ID: 15516847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.
    Yeo TP; Hruban RH; Brody J; Brune K; Fitzgerald S; Yeo CJ
    J Gastrointest Surg; 2009 Aug; 13(8):1487-94. PubMed ID: 19459017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
    DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH
    Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing by cancer site: pancreas.
    Axilbund JE; Wiley EA
    Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic behavior of resected BRCA-mutated pancreatic cancer: Comparison with sporadic pancreatic cancer and other BRCA-related cancers.
    Kim SH; Hwang HK; Lee WJ; Kang CM
    Pancreatology; 2021 Apr; 21(3):544-549. PubMed ID: 33612442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Pancreatic Cancer and the Future of Directed Screening.
    Welinsky S; Lucas AL
    Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathologic features of familial pancreatic cancer.
    Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV;
    Cancer; 2014 Dec; 120(23):3669-75. PubMed ID: 25313458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management strategies for patients with hereditary pancreatic cancer.
    Brentnall TA
    Curr Treat Options Oncol; 2005 Sep; 6(5):437-45. PubMed ID: 16107246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012.
    Wada K; Takaori K; Traverso LW; Hruban RH; Furukawa T; Brentnall TA; Hatori T; Sano K; Takada T; Majima Y; Shimosegawa T
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):557-66. PubMed ID: 23604538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.